StockData
Skye Bioscience, Inc. logo

Skye Bioscience, Inc. (SKYE) stock

SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$1.00−0.06 (-6.10%)

Close on Nov 17, 2026Market cap $35.42MP/E –Yield –

Skye Bioscience revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Skye Bioscience

Skye Bioscience has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Skye Bioscience figures

See a number that looks wrong?